Actos and Skin disorder - a phase IV clinical study of FDA data

Summary:

Skin disorder is reported as a side effect among people who take Actos (pioglitazone hydrochloride), especially for people who are female, 60+ old, have been taking the drug for 5 - 10 years also take Norvasc, and have Nuclear magnetic resonance imaging abdominal.

The phase IV clinical study analyzes which people have Skin disorder when taking Actos. It is created by eHealthMe based on reports of 49,087 people who have side effects when taking Actos from the FDA, and is updated regularly.

What is Actos?

Actos has active ingredients of pioglitazone hydrochloride. It is often used in diabetes. eHealthMe is studying from 49,754 Actos users. Check the latest studies of Actos.

What is Skin disorder?

Skin disorder (skin disease) is found to be associated with 1,545 drugs and 1,448 conditions by eHealthMe. Check the latest studies of Skin disorder.

On Jul, 13, 2026

49,087 people reported to have side effects when taking Actos.
Among them, 78 people (0.16%) have Skin disorder.

Among these 78 people:

How long have people been on Actos when they have Skin disorder? *

What is the gender of people who have Skin disorder when taking Actos? *

female: 67.53 %
male: 32.47 %

What is the age of people who have Skin disorder when taking Actos? *

What are other drugs people take besides Actos? *

What are other side effects people have besides Skin disorder? *

Rashes (redness): 30 people, 38.46%
Itching: 26 people, 33.33%
Pain: 25 people, 32.05%
Skin Exfoliation (removal of the oldest dead skin cells): 16 people, 20.51%
Weakness: 15 people, 19.23%
Nephrogenic Systemic Fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease): 15 people, 19.23%
Skin Hypertrophy (skin cells enlarges): 15 people, 19.23%
Skin Induration (an abnormally hard spot or area on the skin): 15 people, 19.23%
Oedema Peripheral (superficial swelling): 14 people, 17.95%
Skin Discoloration: 14 people, 17.95%

What are the existing conditions these people have? *

Nuclear Magnetic Resonance Imaging Abdominal: 14 people, 17.95%
High Blood Pressure: 12 people, 15.38%
Waldenstrom's Macroglobulinaemia (cancer affects small lymphocytes (white blood cells)): 6 people, 7.69%
Depression: 4 people, 5.13%
High Blood Cholesterol: 4 people, 5.13%
Lung Disorder (lung disease): 3 people, 3.85%
Lymphocytic Leukaemia (a type of cancer in which the bone marrow makes too many lymphocytes): 2 people, 2.56%
Dizziness: 2 people, 2.56%
Haemosiderosis (general increase in tissue iron stores without associated tissue damage): 2 people, 2.56%
Tachyarrhythmia (disturbance of the heart rhythm in which the heart rate is abnormally increased): 2 people, 2.56%

* Approximation only. Some reports may have incomplete information.

Do you take Actos and have Skin disorder?

- Check whether Skin disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Actos:

Actos (49,754 reports)

Skin disorder treatments and more:

Skin disorder (41,532 reports)

Browse all side effects of Actos:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Skin disorder:

Skin disorder (1,545 drugs)

Browse all the conditions that are associated with Skin disorder:

Skin disorder (1,448 conditions)

Related publications that referenced our studies

Moftah NH, Kamel AM, Attia HM, El-Baz MZ, El–Moty HM, "Skin diseases in patients with primary psychiatric conditions: a hospital based study", Journal of epidemiology and global health, 2013 Sep .
Moftah NH, Kamel AM, Attia HM, El-Baz MZ, El–Moty HM, "Skin diseases in patients with primary psychiatric conditions: a hospital based study", Journal of epidemiology and global health, 2013 Sep .

How the study uses the data?

The study uses data from the FDA. It is based on pioglitazone hydrochloride (the active ingredients of Actos) and Actos (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.